VI. Studies on the mechanism of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine cytotoxicity in isolated hepatocytes
- 1 February 1987
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 40 (8) , 741-748
- https://doi.org/10.1016/0024-3205(87)90301-8
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Role of redox cycling and lipid peroxidation in bipyridyl herbicide cytotoxicityBiochemical Pharmacology, 1986
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytesBiochemical and Biophysical Research Communications, 1986
- Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐PhenylpyridiniumJournal of Neurochemistry, 1986
- 1-methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodentLife Sciences, 1986
- Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractionsJournal of Medicinal Chemistry, 1985
- The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metalsBiochemical and Biophysical Research Communications, 1985
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- [4] Isolation and use of liver cellsPublished by Elsevier ,1978